Priser
Platform
Blog
Om os
Download
Al-Dawaa Medical Services
Al-Dawaa Medical Services
SAUDI STOCK EXCHANGE
0

Om

Al-Dawaa Medical Services Co. is a prominent pharmaceutical and healthcare retailer based in Saudi Arabia. Its primary function is to provide a vast array of healthcare products and pharmaceutical services to consumers, enhancing access to essential medicines and wellness products across the region. Al-Dawaa operates a substantial network of pharmacies, making it a pivotal player in the retail pharmacy market in the Middle East. The company ensures a wide distribution of prescription medications, over-the-counter drugs, as well as health and beauty products, thereby supporting public health initiatives and meeting diverse consumer needs. With its extensive reach, Al-Dawaa is crucial in influencing the healthcare sector, enabling convenient access to quality medical supplies and healthcare advice. Moreover, its alignment with current healthcare trends and commitment to customer care underscores its role as a significant driver of growth and efficiency in the regional pharmaceutical market.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I AL-DAWAA MEDICAL SERVICES MED ENDAVU: Køb Al-Dawaa Medical Services ($4163) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Al-Dawaa Medical Services, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker4163
Land
Saudi-Arabien
Antal medarbejdere6.359
Hjemmesideal-dawaa.com.sa
SektorSundhed
IndustriApoteksforhandlere

Udbytter

2,5SAR
'23
2,51SAR
'24
2,52SAR
'25
0,63SAR
'26
Ex-udbytte-dato11. feb. 2026
Udbytteafkast5,01%